DaVita Venture Group logo

DaVita Venture Group

North America, Colorado, United States, Denver

Description

DaVita Venture Group aims to invest in, develop and launch products, solutions and businesses that improve care for patients.

Investor Profile

DaVita Venture Group has made 9 investments, with 1 in the past 12 months and 11% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Series D (22%)
  • Seed (11%)

Country Focus

  • United States (78%)
  • The Netherlands (22%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Health Diagnostics
  • Mhealth
  • Biopharma
  • Medical Device
  • Therapeutics
  • Software
  • Task Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DaVita Venture Group frequently co-invest with?

China Grand Pharmaceutical and Healthcare Holdings
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
MassMutual
North America, Massachusetts, United States, Springfield
Co-Investments: 1
Designer Fund
North America, California, United States, San Francisco
Co-Investments: 1
August Capital
North America, California, United States, Menlo Park
Co-Investments: 1
DigitalDx Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
.406 Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Catalys Pacific
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Echo Health Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
MI
North America, Massachusetts, United States, Springfield
Co-Investments: 1

Which angels does DaVita Venture Group often collaborate with?

Shared Deals: 1

What are some of recent deals done by DaVita Venture Group?

Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series BAug 20, 2024
Amount Raised: $105,000,000
Xeltis

Eindhoven, Noord-Brabant, The Netherlands

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Health CareMedical DeviceTherapeutics
Series DAug 14, 2023
Amount Raised: $13,634,767
Dock Health

Great Barrington, Massachusetts, United States

Dock Health is a healthcare administrative hub that offers task management and administrative workflow automation.

Health CareMedicalSoftwareTask Management
SeedMay 25, 2023
Amount Raised: $5,000,000
Xeltis

Eindhoven, Noord-Brabant, The Netherlands

Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.

Health CareMedical DeviceTherapeutics
Series DFeb 21, 2023
Amount Raised: $34,084,542
Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series AJan 18, 2023
Amount Raised: $150,000,000
Heartbeat Health

New York, New York, United States

Heartbeat Health is a digital health company that utilizes technology to improve cardiovascular disease prevention and management.

Health CareHealth DiagnosticsMedicalmHealthTelehealth
Series BMay 10, 2021
Amount Raised: $20,000,000
Nephrosant

Brisbane, California, United States

NephroSant’s mission is to deliver new diagnostic tools for early detection and lifetime monitoring of kidney health and injury.

BiotechnologyHealth CareHealth Diagnostics
Series AMar 16, 2021
Amount Raised: $16,000,000
SameSky Health

North Hollywood, California, United States

Multicultural engagement and health equity solutions

Health CareMedicalWellness
Series BDec 15, 2020
Amount Raised: $17,000,000
Wellth

Los Angeles, California, United States

Wellth motivates medication adherence using Behavioral Economics

Health CareInformation TechnologymHealthPersonal Health
Series AMay 6, 2020
Amount Raised: $10,000,000